Strome Business Minute With Dr. Jeff Tanner

I’m Jeff Tanner, dean of the Strome College of Business, and this is a Strome Business Minute. Massachusetts-based Moderna announced a successful early stage trial for its COVID vaccine, causing stock prices in the NASDAQ-traded pharma to jump more than sixteen percent on the news overnight. The trial was on forty five patients, all of whom maintained COVID antibodies following two injections. The company is beginning large scale trials next week that will test the vaccine on thirty thousand people world-wide. It requires two doses one month apart. Moderna is one of more than a hundred companies working to develop a vaccine but Moderna has been the fastest, the first to also have something ready even for a preliminary trial. If successful, the vaccine would go into production with three hundred million for early next year. To learn more, visit odu.edu/business. This has been a Strome Business Minute, presented by the Strome College of Business at Old Dominion University.